Inventor · disambiguated record
Chloe Zubieta
Also filed as: ZUBIETA CHLOE · ZUBIETA CHLOÉ
5 granted patents·4 pending applications·0 citations·filing 2001–2020
63Inventor score
Files withEUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL)2SALK INST FOR BIOLOGICAL STUDI2COMMISSARIAT ENERGIE ATOMIQUE1CUSACK STEPHEN1F HOFFMANN-LA ROCHE LTD1
Top patents by PatentIndex Score
9 records- 0169US7966133B2Method of identifying a potential substrates of an O-methyltransferaseSALK INST FOR BIOLOGICAL STUDI·Filed 2008·Granted Jun 21, 2011·0 cites·4 claims
- 0260US7384759B2Methods and compositions for determinig enzymatic activity and specificity of chalcone O-methyltransferasesSALK INST FOR BIOLOGICAL STUDI·Filed 2001·Granted Jun 10, 2008·0 cites·4 claims
- 0359US2011306073A1Method and compositions for determining enzymatic activity and specificity of methyltransferasesNOEL JOSEPH P·Filed 2011·Application pending·0 cites
- 0452US12077767B2Altering thermoresponsive growth in plants via genome editing of phytochrome interacting factor 4 (PIF4) regulatory elementsCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2020·Granted Sep 3, 2024·0 cites·17 claims
- 0550US2018044649A1Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their useEUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL·Filed 2017·Application pending·0 cites
- 0649US2013102600A1Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 0748US9783794B2Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their useEUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL)·Filed 2015·Granted Oct 10, 2017·0 cites·14 claims
- 0847US9181307B2Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their useCUSACK STEPHEN·Filed 2011·Granted Nov 10, 2015·0 cites·14 claims
- 0942US2016297763A1Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseF HOFFMANN-LA ROCHE LTD·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →